Skip to main content

Table 1 Treatment assignment based on core CGA testing

From: A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

  GO-GO arm SLOW-GO arm FRAIL arm
ECOG 0–1 ≤ 2 ≥ 3
G8-Questionaire >  14 points ≤ 14 points <  14 points
ADL (Barthel) = 100 ≤ 100 <  100
IADL = 8 (f) / = 5 (m) ≤ 8 (f) / ≤ 5 (m) <  8 (f) / < 5 (m)
\